Laura & Isaac Perlmutter Cancer Center at NYU Langone — New York, New York

Laura & Isaac Perlmutter Cancer Center at NYU Langone is a clinical research site located in New York, New York, United States 10016.

Crixeo Health Trust Score: 65/100 (FAIR). This profile has not yet been claimed by the site owner.

Laura & Isaac Perlmutter Cancer Center at NYU Langone has participated in 3 clinical trials with 1 currently active.

Therapeutic areas: Renal Cell Cancer, Pancreatic Ductal Adenocarcinoma, Non Small Cell Lung Cancer.

Sponsors: Pfizer, Verastem, Inc., Aduro Biotech, Inc..

Sponsor Feasibility Report

Trust Score: 65/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Laura & Isaac Perlmutter Cancer Center at NYU Langone?

Laura & Isaac Perlmutter Cancer Center at NYU Langone has a Crixeo Trust Score of 65/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Laura & Isaac Perlmutter Cancer Center at NYU Langone conducted?

Laura & Isaac Perlmutter Cancer Center at NYU Langone has 3 clinical trials on record, with 1 currently active. Their work covers Renal Cell Cancer, Pancreatic Ductal Adenocarcinoma, Non Small Cell Lung Cancer.

Is Laura & Isaac Perlmutter Cancer Center at NYU Langone accredited by Crixeo Health?

Laura & Isaac Perlmutter Cancer Center at NYU Langone has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Laura & Isaac Perlmutter Cancer Center at NYU Langone?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.